v
Search
Advanced Search

Publications > Journals > Future Integrative Medicine > Article Full Text

  • Systematic Review
  • OPEN ACCESS

Activity of Brazilian Cerrado Plants in Tumor Cell Lines: A Systematic Review

  • Gabriela Silva Neubern de Oliveira1,
  • Cassia Senger2 and
  • Rodrigo Cardoso de Oliveira1,* 
 Author information
Future Integrative Medicine   2024;3(1):50-62

doi: 10.14218/FIM.2023.00042

Abstract

Background and objectives

Medicinal plants have been recognized as a promising alternative treatment against some types of cancer, being rich sources of effective biochemical agents. The aim of this study, therefore, was to gather, through a systematic literature review, articles related to plants from the Brazilian Cerrado biome that have an action on different tumor cells.

Methods

Different keywords were used in the search mechanisms of Pubmed, Scielo, Science Direct, Scopus, and Lilacs databases. Of the studies found, titles that did not reflect the purpose of this review, those that did not provide access to the full text, and those that were published before 2005 were excluded. Articles referring to the activity of Cerrado plants in tumor cells published in the last sixteen years were selected, totaling thirty-nine articles. Registration number of this review: #CRD42020205579.

Results

The extracts from the studied plants demonstrated significant antiproliferative effects against several tumor cell lines. 39 species of plants were identified belonging to the families: Combretaceae, Annonaceae, Celastraceae, Verbenaceae, Solanaceae, Myrtaceae, Rubiaceae, Bignoniaceae, Erythroxylaceae, Sapotaceae, Asteraceae, Elaeocarpaceae, Apocynaceae, Anacardiaceae, Calophyllaceae, Lythraceae, Mimosaceae, and Morseraceae. The extracts were obtained from different parts of the plants and different fractions were used.

Conclusion

It can be concluded that the Cerrado contains a wide variety of plants with antitumor actions, and further studies are needed to discover other species with anticancer potential, in addition to in vivo studies.

Keywords

Cerrado, Medicinal plants, Cancer, Tumor cell

Introduction

Cancer is characterized by uncontrolled cell growth or cell proliferation capable of invading other tissues. There are approximately one hundred types that are named for the tissue, organ, or cell type in which the disease begins. Chemicals, radiation, inadequate diet, infection, environmental factors, and smoking are some of the main risk factors.1 The disease is a relevant problem for public health and the treatment represents an obstacle, as it is often unsuccessful. It is considered the main cause of death in developed countries and the second in developing countries, leading to a considerable increase in health costs and the great need for a better understanding of its mechanisms to control the disease through the development of more effective therapies.2,3

Concerning cancer treatment, medicinal plants represent a promising alternative. These are a source of important bioactive molecules with wide structural diversity that generally demonstrate less toxicity and greater selectivity against tumor cells.4 Furthermore, they have also been shown to decrease the side effects induced by synthetic drugs and increase the survival rate for many patients.5 Moreover, it is recognized that many natural products have a rich chemical diversity, being a source for the identification of new structures and, consequently, for the manufacture of new drugs.6 Currently, the sources of natural products used for developing drugs against cancer include, in addition to plants, marine organisms and microorganisms, being more diversified now than in the past. However, plants remain a promising source of natural products for chemoprevention, as about 25% of currently available therapies derive from plants.7,8

The Cerrado, known as the “Savanna of the Tropical Lands”, is a Brazilian biome that occupies about 20% of the national territory. The vegetation, quite heterogeneous, with taxonomic biodiversity that is even greater than that of the Amazon Forest, occurs especially in the states of Mato Grosso, Goiás, Minas Gerais, São Paulo, and Ceará. The region is considered a global biodiversity hotspot and contains several plant species that are widely used in folk medicine and scientific research. Due to its considerable diversity, there is a growing interest in the Cerrado regarding the discovery of new medicinal plants with bioactive compounds (http://www.mma.gov.br/biomas/Cerrado ).9,10 The species present in the biome are already used by local communities for the treatment of several diseases and research with biological models has already demonstrated the promising potential of several molecules from these species.11 The beneficial action of its plants has already been proven in inflammatory processes against microorganisms and cancer, among other diseases.12

The search for new drugs that exhibit action against various types of tumors is one of the most interesting topics in the field of natural product research.13 In this area, plants are considered very promising, since their derivatives are widely used for cancer control. An example is Catharanthus roseus (Apocynaceae), a plant from which Vinblastine (Velban®) and Vincristine (Oncovin®) were isolated and used in the treatment of various types of tumors.14 Interruption of the cell cycle, induction of apoptosis, and inhibition of angiogenic factors in cancer cells are important effects associated with these plant-based drugs.15 In this sense, the Cerrado stands out, as many compounds with important biological activities have already been obtained from plants in this biome.13

Given the importance of the above subject, this study aimed to gather and discuss, through a systematic literature review, articles related to plants from the Brazilian Cerrado biome that have action on different tumor cells.

Methods

The present systematic review is registered in the PROSPERO database (International Prospective Register of Systematic Reviews) under registration number #CRD42020205579.

Types of study

Articles related to the effects of plants from the Brazilian Cerrado biome on human and animal tumor cells that used plausible control groups for the study (untreated, vehicle, treated vehicle, and standard chemotherapeutics), in vitro, published between 2005 and 2020, in English or Portuguese languages were included. Methods, time, and concentration of extracts/compounds were not considered. The information about the plants gathered in this article includes species, popular name, part of the plant used, type of extract, target cell, probable main active of the extracts, and mode of action.

Search strategy

Our research on the action of Brazilian Cerrado plants on tumor cells was carried out using Pubmed, Science Direct, and Scopus. Date filter (2005–2020), full text, and article type (research articles) were applied. The search included free text and medical subject heading terms: 1) Cerrado plants and Tumor Cell Lines; 2) Medicinal Plants and Cerrado and Tumor Cell Lines; 3) Medicinal Herbs and Cerrado and Tumor Cell Lines; 4) Phytotherapy and Cerrado and Tumor Cell Lines, and 5) Pharmaceutical Plants and Cerrado and Tumor Cell lines. The last survey update was in January/2021 (Fig. 1).

Flowchart of study selection.
Fig. 1  Flowchart of study selection.

Results

A total of 225 scientific articles were selected from the five databases consulted. After excluding duplicate titles, unrelated abstracts, and “not open access” articles, 35 articles remained. After a free search, 4 articles were included, totaling 39 scientific articles. Thirty-nine plant species are cited, along with the popular name, part of the plant used, type of extract, target cell, and reference (Table 1).8,12,16–53 The species are distributed among 33 genera and 20 families. The families include: Combretaceae (Terminalia fagifolia), Annonaceae (Annona coriaceae, Annona crassiflora, Cardiopetalum calophyllum), Celastraceae (Austroplenckia populnea, Salacia crassifolia, Maytenus ilicifolia), Verbenaceae (Lippia salviaefolia), Solanaceae (Solanum lycocarpum), Myrtaceae (Myrcia falax, Myrcia bella, Campomanesia adamantium, Myrcia guianensis, Psidium guineense), Rubiaceae (Palicourea rigidum, Ixora brevifolia), Bignoniaceae (Pyrostegia venusta, Tabebuia avellanedae), Erythroxylaceae (Erythroxylum suberosum, Erythroxylum daphnites and E. subrotundum), Sapotaceae (Pouteria pie, Pouteria ramiflora), Asteraceae (Calea pinnatifida, Chresta sphaerocephala, Eremanthus matogrossensis, Eremanhus seidelii and Lychnophora trichocarpha), Elaeocarpaceae (Sloanea garckeana), Apocynaceae (Calotropis procera), Anacardiaceae (Anacardium humile), Calophyllaceae (Kielmeyera coriacea), Lythraceae (Lafoensia pacari), Mimosaceae (Mimosa caesalpiniifolia), Burseraceae (Protium ovatum), Faba ceae (Senna velutina, Dipteryx alata Vog, Stryphnodendron adstringens and Zornia brasiliensis) and Moraceae (Brosimum gaudichaudii) (Table 1).

Table 1

Description of details about plant species of Brazilian Cerrado, popular name, parts used, type of extract (fraction), tumor cell lines, and references

SpeciesPopular nameUsed part of the plantExtract typeTarget cellReferences
Anacardium humile
Brosimum gaudichaudii
Tabebuia avellanedae		‘Cajuzinho’
‘Inharé’
‘Purple ipê’		Bark (c) and leaves (f)
Bark (c) and leaves (f)
Bark (c) and leaves (f)		EthanolicNCI- H292 (lung) (−)
HEp-2 (larynx) (−)
HT-29 (colon) (−)
HL-60 (promyelocytic leukemia) (−)
MCF-7 (breast) (C, F,+)
NCI- H292 (F, +), HEp-2 (−)
HT-29 (F, +), HL-60 (−)
MCF-7 (C, +)
NCI- H292 (−), HEp-2 (F +)
HT-29 (−), HL-60 (F +)
MCF-7 (−)		16
Annona coriácea‘ Marola’
‘Araticum-liso’		SeedsMethanolicUACC-62 (melanoma), MCF-7 (breast), NCI/ADR/RES (ovary), 786-0 (kidney), NCI-H460 (lung), OVCAR-3 (ovary), HT-29 (colon), K562 (leukemia), UA251 (glioma) (+)17
Annona crassiflora‘Araticum’Seeds and barkPhenolicNCI/ADR/RES (ovary) (+)
U251 (glioma) (+)
MCF-7 (breast) (+)
NCI-H460 (lung) (−)
PC-3 (prostate) (+)
OVCAR-03 (ovary) (+)
HT-29 (colon) (+)
K562 (leukemia) (+)		18
Austroplenckia
Populnea		‘Mangabarana’
‘Marmelo-do-campo’
‘Mangabeira-brava’		FruitPure compounds (proanthocyanidin A and 4′-O-methyl-epigallocatechin)
Three pure extracts (ethanol, ethyl acetate and chloroform)		A549 (lung) (+)
HS578T (breast) (+)
MCF-7 (breast) (+)
A549 (−)
HS578T (−), MCF-7 (−)		19
Calea pinnatifida‘Quebra-tudo’
‘Cipó-cruz’
‘Aruca’		LeavesDichloromethaneUACC-62 (melanoma) (+)
MCF-7 (breast) (+)
786-O (kidney) (+)
NCI-ADR/RES (ovary) (+)
NCI-H460 (lung) (+)
PC-3 (prostate) (+)
OVCAR-3 (ovary) (+)
HT29 (colon) (+)
K-562 (leukemia) (+)		20
Calotropis procera‘Algodão de seda’
‘Leiteiro’
‘Queimadeira’
‘Ciúme’		BarkEthyl acetate, acetone
Hexane, methanolic dichloromethane		B-16/F10 (melanoma - murine) (+)
HCT-8 (human colon) (+)
CEM (human leukemia) (+)
B-16/F10 (−)
HCT-8 (−)
CEM (−)		21
Campomanesia adamantium
Cardiopetalum calophyllum
Protium ovatum		‘Guavira’
‘Imbirinha’
‘Almecega’		Leaves
Leaves
Leaves
Green fruits		Essential oilMCF-7 (breast) (+)
HeLa (cervical) (+)
M059J (glioblastoma) (+)
MCF-7 (+), HeLa (+), M059J (+)
MCF-7 (−), HeLa (−), M059J (+)
MCF-7 (−), HeLa (−), M059J (−)		22
Chresta sphaerocephala‘João-bobo’Leaves
Bark (B)		Hexanic (L)
Hexanic (B)
Methanolic
Ethyl acetate		U251 (glioma) (+), UACC-62 (melanoma) (+)
MCF7 (breast) (−), NCI-ADR/RES (ovary) (+)
786-0 (kidney) (+), NCI-H460 (lung) (+)
OVCAR-3 (ovary) (+), PC-03 (prostate) (+)
HT29 (colon) (+) e K-562 (leukemia) (+)
U251 (−), UACC-62 (+), MCF-7 (+)
NCI-ADR/RES (−), 786-0 (−), NCI-H460 (−)
OVCAR-3 (+), PC-3 (+), HT29 (−), K-562 (+)
Showed no antiproliferative effect
Showed no antiproliferative effect		12
Dipteryx alata Vog.‘Baru’SeedsPhenolicHT29 (colon) (+)23
Eremanthus matogressensis
Eremanthus seidelii		Uninformed
Uninformed		Leaves
Leaves		Isolated compound
isolated compound		T98G (+) e U87MG (+) (glioblastoma)
T98G (−), U87MG (−)		24
Erythroxylum daphnites‘Fruta-de-pomba’LeavesHexanicSCC-9 (oral) (+)25
Erythroxylum daphnites
Erythroxylum suberosum
Erythroxylum subrotundum
Pouteria ramiflora
Pouteria torta		‘Mercurinho’
‘Fruta-de-veado’		Leaves
Leaves
Leaves
Leaves
Leaves		Aqueous
Ethanolic
Hexanic
Aqueous
Ethanolic
Hexanic
Aqueous
Ethanolic
Hexanic
Aqueous
Ethanolic
Hexanic		FaDu (−), SCC-25 (−), SCC-9 (−)
FaDu (−), SCC-25 (−), SCC-9 (−)
FaDu (−), SCC-25 (+), SCC-9 (+)
FaDu (+), SCC-25 (+), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (+)
FaDu (−), SCC-25 (−), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (−)
FaDu (−), SCC-25 (−), SCC-9 (−)
FaDu (−), SCC-25 (−), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (−)
SCC-25, SCC-9 (tongue)/FaDu (hypopharynx)
FaDu (+), SCC-25 (−), SCC-9 (−)
FaDu (+), SCC-25 (−), SCC-9 (−)
FaDu (−), SCC-25 (−), SCC-9 (−)		26,27
Erythroxylum
suberosum		‘Cabelo-de-negro’LeavesAqueous
Ethanolic
Hexanic		SCC-9 (oral) (+)
FaDu (hypopharynx) (+)
SCC-9 (−), FaDu (+)
SCC-9 (−), FaDu (−)		28
Ixora brevifolia‘Ixora-arborea’TwigsCrude and hydroethanolic extract, hexanicU251 (glioma) (+)
K562 (leukemia) (+)		29
Kielmeyera coriacea‘Pau-santo’Fruits and LeavesEssential oilMDA-MB-231(breast) (+)
DU-145 (prostate) (+)
MDA-MB-231 (−)
DU-145 (−)		30
Kielmeyera coriacea‘Pau-santo’Root barkHexanicHL-60 (leukemia) (+)
HCT-8 (colon) (+)
MDA-MB-435 (breast) (+)
SF-295 (glioblastoma) (+)		31
Kielmeyera coriaceaUninformedLeavesChloroform
Hydroalcoholic
Ethyl acetate
Hexanic
Heptane		B16F10-Nex2 (melanoma murino) (+)
HCT (colon) (+), Siha (cervical) (+)
A2058 (melanoma) (+), SKmel28 (melanoma) (+) and MeWO (melanoma) (+)
B16F10-Nex2 (−)
B16F10-Nex2 (−)
B16F10-Nex2 (−)
B16F10-Nex2 (−)		32
Lafoensia pacari‘Dedaleira’
‘Mangava-brava’		Stem barkMethanolicTRH- 18 (+) (colorectal)33
Lafoensia pacari‘Dedaleira’
‘Mangava-brava’		Stem barkEthanolicH460 Human NSCLC (lung) (+)
A549 (NSCLC, adenocarcinoma) (+)
H2023 (NSCLC, adenocarcinoma) (+)
E9 murina (lung) (+)		34
Lafoensia pacari‘Dedaleira’
‘Mangava-brava’		Stem barkMethanolic and fractionsU-937 (+), Jurkat
Daudi (leukemia) (+)		35
Lippia salviaefoliaUninformedAerial partsAromadendrin
Phloretin		HEK-293 (kidney) (−)
M14 (melanoma) (+)
HEK-293 (+)		36
Lychnophora trichocarpha
Spreng.		‘Arnica
brasileira’		Aerial partsEthanolic
Lychnopholide		30 human tumor cell lines37
Maytenus ilicifolia‘Espinheira santa’Root barkEthanolicHL-60 (leukemia) (+)
K-562 (chronic myelocytic leukemia) (+)
SF-295 (glioblastoma) (+)
HCT- 8 (colon) (+)
MDA/MB-435 (melanoma) (+)		38
Mimosa caesalpiniifolia‘Sabiá’
‘Sansão-do-campo’		LeavesEthanolicMCF-7 (breast) (+)39
Myrcia bella‘Mercurinho’LeavesHydroalcoholicACP02 (gastric) (+)40
Myrcia bella
Myrcia falax
Myrcia guianensis		‘Jacarezinho’
Uninformed
Uninformed		Leaves
Leaves
Leaves		HydroethanolicK562 (+), MCF-7 (+),
786-0 (−), NCI-H460 (−)
PC-3 (−), HT-29 (−)
K562 (+), MCF-7 (−),
786-0 (−), NCI-H460 (−)
PC-3 (−), HT-29 (−)
K562 (leukemia) (+), MCF-7 (breast) (+)
786-0 (kidney) (−), NCI-H460 (lung) (−)
PC-3 (prostate) (−), HT-29 (colon) (−)		27,41
Palicourea rígida‘Douradão’LeavesEthanolic extract (isolated compound)SK-MEL-37 (melanoma) (+)42
Pouteria tortaa‘Guapeva’LeavesHexanic
Ethanolic
Aqueous		OSCC-3 (oral) (+)
MCF-7 (breast) (+)
OSCC-3 (+)
MCF-7 (+)
OSCC-3 (+)
MCF-7 (+)		43
Psidium guineense‘Goiabinha-araçá’
‘Araçá-do-campo’
‘Araçá verdadeiro’
‘Goiabinha selvagem’		LeavesEssential oilOVCAR-3 (ovary) (+)
U251 (glioma) (+), MCF-7 (breast) (+)
NCI-ADR/RES (ovary) (+), 786-0 (kidney) (+)
NCI-H460 (lung) (+), PCO-3 (prostate) (+)
HT-29 (colon) (+), K-562 (leukemia) (+)		44
Pyrostegia venusta‘St. John vine’FlowersHeptane
Hydroalcoholic		B16F10-Nex2 (murine melanoma) (+)
B16F10-Nex2 (−)		45
Salacia crassifolia‘Bacupari-do-Cerrado’
‘Saputá’
‘Seputá’		Stem barkHexanic
Dichloromethane
Ethyl acetate
Hydroalcoholic
Hexanic
Dichloromethane
Ethyl acetate
Hydroalcoholic
Hexanic
Dichloromethane
Ethyl acetate
Hydroalcoholic		MDA-MB-435 (melanoma) (+)
MDA-MB-435 (−)
MDA-MB-435 (−)
MDA-MB-435 (−)
HCT-8 (colon) (+)
HCT-8 (−)
HCT-8 (+)
HCT-8 (−)
SF-295 (central nervous system) (+)
SF-295 (−)
SF-295 (−)
SF-295 (−)		46
Salacia crassifolia‘Bacupari-do-Cerrado’Root woodHexanicColo205 e KM12 (colon) (+)
A498 e U031 (kidney) (+)
HEP3B and SKHEP (liver) (−)
MG63 and MG63.3 (osteosarcoma) (+)		47
Senna velutina‘Fedegosão’LeavesEthanolicJurkat (+) e K562 (+) (leukemia)27,48
Solanum lycocarpum‘Fruit-of-wolf’
‘Lobeira’ or ‘Jurubebão’		FruitGlycoalkaloidHepG2 (liver) (+)
B16F10 (murine melanoma) (+)
HT29 (colon), MCF-7 (breast) (+)
HeLa (cervical) (+), HepG2 (liver) (+)
MO59J, U343 e U251 (glioblastoma) (+)		49
Sloanea garckeanaa‘Urucurana Brava’LeavesMethanolic
Hexanic
Chloroform
Ethyl acetate		UACC-62 (melanoma) (+), NCI-460 (lung) (+)
MCF-7(breast) (+), NCI-ADR (breast) (+)
HT-29 (colon) (+), OVCAR (ovary) (+)
C786-0 (kidney) (+) e PCO-3 (prostate) (+)		50
Stryphnodendron adstringens‘Barbatimão’ or ‘Casca-da-mocidade’Stem barkAqueousB16F10Nex-2 (melanoma) (+)51
Terminalia fagifolia‘Capitão-do-mato’
‘Mirindiba’
‘Pau-de-bicho’		Bark and leavesEthanolicPC3 (prostate) (+)
B16F10 (murine melanoma) (+)		52
Terminalia fagifolia‘Capitão’
‘Capitão -do-Cerrado’
‘Capitão-do-campo’
‘Mirindiba’		Stem barkEthanolic
and fractions		MCF-7 (breast) (+)8
Zornia brasiliensis‘Urinária’
‘Urinana’
‘Carrapicho’		Aerial partsEthanolicHL60 (promyelocytic leukemia) (+)
MCF-7 (breast) (−)
HCC1954 (breast) (−)
T-47D (breast) (−)
4T1 (breast) (−)
HL60 (promyelocytic leukemia) (−)		53

Data set from all relevant studies. aSource: https://www.sibbr.gov.br/ . (+) , effect on tumor cells; (−), null or very low effect.

The major components of the extracts and probable mode of action on tumor cells are presented in Table 2. In general, the major effects of plant compounds are on the modulation of the cellular cycle (proliferation, DNA synthesis, and apoptosis) of tumor cell lines. Some compounds (flavonoids) have free radicals scavenging and antioxidant capacities (Table 2, Fig. 2).16,18–21,24–26,30,31,33,36–46,48–53

Table 2

Description of details of Brazilian Cerrado plant species, major compounds, and probable mode of action

SpeciesCompound and mode of actionReferences
Anacardium humile
Erythroxylum suberosum
Myrcia falax
Sloanea garckeana
Tabebuia avellanedae
Terminalia fagifolia
Zornia brasiliensis		Phenolic compounds - free radical scavenging (A. humile) (T. fagifolia)
Flavonoids - free radical scavenging, prevention of cancer progression, DNA repair and stimulation of the immune system, and an ability to effect the pathway that regulates cell growth and proliferation and tumor formation (T. avellanedae)		16,50,53
Annona crassiflora
Austroplenckia populnea
Brosimum gaudichaudii
Lippia salviaefolia
Myrcia bella
Senna velutina		Flavonoids - antioxidant; free radical scavenging, DNA repair, and immune system stimulation16,18,19,36,40,48
Calea pinnatifidaSesquiterpenes (germacranolides) - potent induction of apoptosis and inhibition of nuclear factor kappa B20
Calotropis proceraCardiotonic glycoside steroids - activation of apoptotic pathways21
Chresta sphaerocephala
Erythroxylum daphnites
Erythroxylum subrotundum
Pouteria ramiflora
Pouteria torta
Salacia crassifólia		Triterpenes - inhibition of tumor growth and cell cycle progression and induction of apoptosis of tumor cells in vitro and in vivo25,43,46
Dipteryx alata
Myrcia spp		Phenolic compounds
Gallic acid (GA) - regulation of several signaling pathways; inhibit proliferation
Gallotannins (GT) - suppression of NFκB activation induced by tumor necrosis factor (TNF-α)
Antioxidants		41,52
Eremanthus matogressensis
Eremanthus seidelii		Sesquiterpene lactones (goyazensolide and lychnofolide) - possible interference in angiogenesis internally and in tumor microenvironment remodeling externally through the ability to degrade proteoglycans24
Erythroxylum suberosum
Mimosa caesalpiniifolia		Catechins - antioxidant26,39
Kielmeyera coriaceaElemen-type sesquiterpenes - inhibition of cell proliferation, stimulation of apoptosis, and induction of cell cycle arrest in the malignant cell30
Kielmeyera coriaceaδ-tocotrienol and dimer - arrest of cell cycle progression/induction of cell apoptosis31
Lafoensia pacariElagitannins - apoptogenic effects
Ellagic acid - regulation of cyclin E (up-regulation), A and B1 (down-regulation) levels, ability to retain cells in the G1/S phase of the cell cycle		33
Lychnophora trichocarphaSesquiterpene lactones - inhibition of enzymes involved in essential biological processes such as DNA and RNA synthesis, protein and purine synthesis, glycolysis, the citric acid cycle, and the mitochondrial electron transport chain.37
Maytenus ilicifoliaPristimerin (triterpenoid) - inhibition of DNA synthesis and ability to trigger apoptosis38
Palicourea rigidaMonoterpenic indole alkaloid called vallesiachotamine - promotion of G0/G1 cell cycle arrest, apoptosis, and necrosis.42
Psidium guineenseSesquiterpenic alcohol - induction of apoptosis44
Pyrostegia venustaAlkanes - induction of cell cycle arrest and apoptosis45
Senna velutinaFlavonoids (epigallocatechin, epicatechin, kaempferol heteroside, rutin) and dimeric and trimeric proanthocyanidin derivatives - induction of leukemic cell death by activating intracellular calcium and caspase-3, ability to decrease mitochondrial membrane potential and interrupt the cell cycle in S and C phases G2.48
Solanum lycocarpum
Ixora brevifolia		Alkaloids - ability to change cell morphology and DNA - irreversible apoptosis, regulation of caspases, regulation of death receptor expression (Example: Tumor necrosis factor receptor I (TNFR-I)).29,49
Stryphnodendron adstringensPhenolic compounds and polyphenols
Gallic acid, gallocatechin, epigallocatechin, dimeric and trimeric proanthocyanidins - antioxidant activity through direct scavenging of free radicals, oxidative hemolysis, inhibition of lipid peroxidation in human erythrocytes, apoptosis-induced cell death through increased levels of intracellular reactive oxygen species (ROS), and induction of mitochondrial membrane potential dysfunction and caspase-3 activation		51

Each compound, found in a specific plant, has a possible mode of action or a target.

Chemical structures of some of the major compounds mentioned in .
Fig. 2  Chemical structures of some of the major compounds mentioned in Table 2.

All plants and their main information (photos, geographic distribution, etc.) can be found on the main platform: http://floradobrasil.jbrj.gov.br .

Discussion

A total of thirty-nine species of medicinal plants from the Brazilian Cerrado biome that have antitumor properties were identified. The species are distributed among 33 genera and 20 families. In most previous studies leaves were used to carry out the tests, and their use as sources of active compounds is a relevant strategy for the sustainable management of endemic species, since it does not compromise the survival of the species.54 In addition to the leaves, stem, trunk bark, root bark, flowers, fruits, seeds, essential oils, and isolated compounds were also used. It must be considered here that different parts of the same plant can synthesize and accumulate different secondary metabolites or different amounts of a certain compound.55

The main compounds responsible for the antitumor potential and for several other pharmacological activities, such as antimicrobial, antioxidant, anti-inflammatory effects against intestinal and respiratory diseases include cardiotonic glycoside steroids (C. procera), phenolic compounds and tannins (A . humile), alkaloids (S. lycocarpum), phenolic acids (A. coriacea), flavonoids - quercetin (A. crassiflora), triterpenes (M. ilicifolia, P. torta, C. sphaerocephala), sesquiterpenes – germacranolides - (C. pinnatifida), flavonoids (E. suberosum, A. populnea, A. coriacea, T. avellanedae, L. salviaefolia, C. procera; E. suberosum; M. caesalpiniifolia, M. bella, M. falax, S. velutina; E. subrotundum, P. ramiflora), spathulenol, germacrene-B and β-caryophyllene oxide (C. adamantium leaves); spathulenol, β-caryophyllene, and β-myrcene (P. ovatum leaves); β-myrcene, α-pinene and limonene (P. ovatum green fruits), spathulenol, viridiflorol, and (Z,E)-farnesol (C. calophyllum leaves), oleic acid and phenolic compounds - gallic acid (D. alata Vog ., S. adstringens), sesquiterpene lactones (L. trichocarpha, E. matogressensis; E. seidelii), triterpenes (E. daphnites), catechins (E. suberosum), lignan syringaresinol and cyclopeptide alkaloids (I. brevifolia), D- germacrene, neo-intermedeol, bicyclogermacrene, Viridiflorol, Globulol, Epi-α-muurolol and δ-cadinene (K. coriacea), δ-tocotrienol and its dimer (K. coriacea), 1-eicosanol, 1-docosanol, and 2- nonadecane (K. coriacea), ellagic acid and others (L. pacari), isomers of galoyl glucose (M. guianensis), monoterpene indole alkaloid (P. rigida), sesquiterpene alcohol spathulenol (P. guineense), alkane (P. venusta)), triterpenes, quinonamethides (S. crassifolia), phenolic compounds (S. garckeana, S. adstringens; T. fagifolia; Z. brasilienses), polyphenols (S. adstringens) and zornioside (Z. brasilienses).

Of all the compounds with antitumor properties presented above, flavonoids appear most frequently. The anticancer action of flavonoids occurs through their effect on the scavenging of free radicals, DNA repair, and stimulation of the immune system.8 In general, the compounds present different modes of action: 1) Arrest of cell cycle progression/induction (triterpenes, gallic acid, element-type sesquiterpenes, δ-tocotrienol and dimer, ellagic acid, monoterpenic indole alkaloid, alkanes)20,25,31,33,41,42,45; 2) Inducer apoptosis (sesquiterpenes, cardiotonic glycoside steroids, Triterpenes, δ-tocotrienol and dimer, elagitannins, pristimerin, alkanes, alkaloids)20,21,25,31,33,38,42,45; 3) Inhibition of nuclear factor kappa B (sesquiterpenes, gallotannins)20,52; 4) Inhibition of DNA synthesis (sesquiterpene lactones, pristimerin),37,38 and 5) DNA repair (flavonoids).16Table 2 presents the major component of the species and the probable mode of action in inhibiting tumor cells. It is noteworthy that plant extracts have thousands of active compounds; here we have gathered just a few of the compounds that were identified in the research.

Cancer cell lines used in previous research include breast, brain, colon, lung, blood, skin, liver, kidney, prostate, ovary, mouth, larynx, and stomach cells, the majority of which are of human origin. According to Caneschi et al.19 and as mentioned by Liu et al.,56 some cell types, such as lung and breast, are more frequently used because they are widely studied in research involving analysis. cytotoxic and because they can be easily used for comparison with different compounds. Regarding the nature of the study, the research used in vitro assays, or more specifically, cell culture. This is an accepted substitute for animal models as its application reduces the number of animal experiments, which is a relevant characteristic of this method.57 Furthermore, these methods are inside the 3Rs principles: replacement, reduction, and refinement, providing stimulation for alternative research, reduction of the use of animals, and an ethical framework for researchers.58,59

Regarding the type of extract, we can verify that ethanolic, methanolic, phenolic, hexane, aqueous, chloroform, hydroalcoholic, hydroethanolic, heptanoic, glycoalkaloid, ethyl acetate, and acetone extracts were used depending on the solvent used to prepare the extract as different solvents produce higher or lower extractive yields and show differences in polarity and, consequently, in the class of compounds extracted from the extract; ethanolic and aqueous extracts, for example, which are the most polar, are rich in polyphenols.28Table 1 shows the types of extracts and details that were discussed in this review, which include species, common name, plant part used, and target cell. In front of each cell line, a positive or negative sign was placed; the sign (+) means that the extract inhibited the tumor cell (regardless of the method) and the sign (−) indicates a null or very low effect. Differences are seen according to the solvent used and this fact is due to the compounds that are extracted according to the solvent, as discussed above.

Conclusion

In view of the data, we conclude that the Brazilian Cerrado biome contains a wide variety of species with antitumor properties and more detailed research is needed to isolate bioactive secondary metabolites with cytotoxic properties. The evaluation of the chemical structure of these compounds is capable of enabling more extensive biological evaluations; thus, additional studies with the fractionated extracts and isolated compounds should be carried out to determine the complete antitumor therapeutic potential of these plants and, also, as future studies, in vivo assays. Moreover, further studies are needed to discover other Cerrado species with antitumor potential.

Declarations

Acknowledgement

We would like to thank to Bauru School of Dentistry and the University of São Paulo.

Data sharing statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Funding

We would like to thank Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for its financial support (#308897/2021-8). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) Finance Code – 001.

Conflict of interest

The authors declare no conflict of interests.

Authors’ contributions

Study concept and design (GSNO, RCO), acquisition of data (GSNO, CS), analysis and interpretation of data (GSNO), drafting of the manuscript (GSNO, CS), critical revision of the manuscript for important intellectual content (GSNO, CS, RCO). All authors have made a significant contribution to this study and have approved the final manuscript.

References

  1. Ahmad R, Ahmad N, Naqvi AA, Shehzad A, Al-Ghamdi MS. Role of traditional Islamic and Arabic plants in cancer therapy. J Tradit Complement Med 2017;7(2):195-204 View Article PubMed/NCBI
  2. Orang-Ojong BB, Munyangaju JE, Wei MS, Lin M, Wei FG, Foukunang C, et al. Impact of natural resources and research on cancer treatment and prevention: A perspective from Cameroon. Mol Clin Oncol 2013;1(4):610-620 View Article PubMed/NCBI
  3. Inacio KK, Pessoa AS, Tokuhara CK, Pagnan AL, Sanches MLR, Fakhoury VS, et al. Menadione and protocatechuic acid: A drug combination with antitumor effects in murine osteosarcoma cells. Arch Biochem Biophys 2024;751:109840 View Article PubMed/NCBI
  4. Torquato HF, Goettert MI, Justo GZ, Paredes-Gamero EJ. Anti-Cancer Phytometabolites Targeting Cancer Stem Cells. Curr Genomics 2017;18(2):156-174 View Article PubMed/NCBI
  5. Yu Z, Zhang T, Zhou F, Xiao X, Ding X, He H, et al. Anticancer Activity of Saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell. Evid Based Complement Alternat Med 2015;2015:725023 View Article PubMed/NCBI
  6. Pessoa AS, Tokuhara CK, Fakhoury VS, Pagnan AL, Oliveira GSN, Sanches MLR, et al. The dimerization of methyl vanillate improves its effect against breast cancer cells via pro-oxidant effect. Chem Biol Interact 2022;361:109962 View Article PubMed/NCBI
  7. Pagnan AL, Pessoa AS, Tokuhara CK, Fakhoury VS, Oliveira GSN, Sanches MLR, et al. Anti-tumour potential and selectivity of caffeic acid phenethyl ester in osteosarcoma cells. Tissue Cell 2022;74:101705 View Article PubMed/NCBI
  8. de Araujo AR, Quelemes PV, Perfeito ML, de Lima LI, Sá MC, Nunes PH, et al. Antibacterial, antibiofilm and cytotoxic activities of Terminalia fagifolia Mart. extract and fractions. Ann Clin Microbiol Antimicrob 2015;14:25 View Article PubMed/NCBI
  9. Correia AF, Silveira D, Fonseca-Bazzo YM, Magalhães PO, Fagg CW, da Silva EC, et al. Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species. BMC Complement Altern Med 2016;16:203 View Article PubMed/NCBI
  10. Fakhoury VS, Pessoa AS, Tokuhara CK, Pagnan AL, Oliveira GSN, Liessa MRS, et al. Evaluation of Myrcia bella in murine osteosarcoma cells: Effect of the extract and enriched fractions of tannins and flavonoids. Nat Prod Res 2022;36(22):5823-5827 View Article PubMed/NCBI
  11. Albernaz LC, de Paula JE, Romero GA, Silva Mdo R, Grellier P, Mambu L, et al. Investigation of plant extracts in traditional medicine of the Brazilian Cerrado against protozoans and yeasts. J Ethnopharmacol 2010;131(1):116-121 View Article PubMed/NCBI
  12. Costa LSD, Andreazza NL, Correa WL, Cunha IBDS, Ruiz ALTG, Carvalho JED, et al. Antiproliferative activity, antioxidant capacity and chemical composition of extracts from the leaves and stem of Chresta sphaerocephala. Rev Bras Farmacogn 2015;25(4):369-374 View Article
  13. de Mesquita ML, de Paula JE, Pessoa C, de Moraes MO, Costa-Lotufo LV, Grougnet R, et al. Cytotoxic activity of Brazilian Cerrado plants used in traditional medicine against cancer cell lines. J Ethnopharmacol 2009;123(3):439-445 View Article PubMed/NCBI
  14. dos Santos Júnior HM, Oliveira DF, de Carvalho DA, Pinto JM, Campos VA, Mourão AR, et al. Evaluation of native and exotic Brazilian plants for anticancer activity. J Nat Med 2010;64(2):231-238 View Article PubMed/NCBI
  15. Mohammadi-Motlagh HR, Shokohinia Y, Mojarrab M, Rasouli H, Mostafaie A. 2-Methylpyridine-1-ium-1-sulfonate from Allium hirtifolium: An anti-angiogenic compound which inhibits growth of MCF-7 and MDA-MB-231 cells through cell cycle arrest and apoptosis induction. Biomed Pharmacother 2017;93:117-129 View Article PubMed/NCBI
  16. Araújo TADS, Sobrinho TJDSP, Aguiar JDS, Silva ACOD, Brito FU, Silva GD, et al. Phytochemical, antioxidant and cytotoxic analysis of Brazilian Cerrado plants: Preliminary evidence of their antitumor activity. J Med Plants Res 2015;9(9):310-319 View Article
  17. Formagio AS, Vieira MC, Volobuff CR, Silva MS, Matos AI, Cardoso CA, et al. In vitro biological screening of the anticholinesterase and antiproliferative activities of medicinal plants belonging to Annonaceae. Braz J Med Biol Res 2015;48(4):308-315 View Article PubMed/NCBI
  18. Prado LG, Arruda HS, Peixoto Araujo NM, de Oliveira Braga LE, Banzato TP, Pereira GA, et al. Antioxidant, antiproliferative and healing properties of araticum (Annona crassiflora Mart.) peel and seed. Food Res Int 2020;133:109168 View Article PubMed/NCBI
  19. Caneschi CM, Muniyappa MK, Duarte LP, Silva GD, Dos Santos OD, Spillane C, et al. Effect of constituents from samaras of Austroplenckia populnea (Celastraceae) on human cancer cells. J Intercult Ethnopharmacol 2015;4(1):6-11 View Article PubMed/NCBI
  20. Marchetti GM, Silva KA, Santos AN, Sousa IM, Tinti SV, Figueira GM, et al. The anticancer activity of dichloromethane crude extract obtained from Calea pinnatifida. J Exp Pharmacol 2012;4:157-162 View Article PubMed/NCBI
  21. Magalhães HI, Ferreira PM, Moura ES, Torres MR, Alves AP, Pessoa OD, et al. In vitro and in vivo antiproliferative activity of Calotropis procera stem extracts. An Acad Bras Cienc 2010;82(2):407-416 View Article PubMed/NCBI
  22. Alves CCF, Oliveira JD, Estevam EBB, Xavier MN, Nicolella HD, Furtado RA, et al. Antiproliferative activity of essential oils from three plants of the Brazilian Cerrado: Campomanesia adamantium (Myrtaceae), Protium ovatum (Burseraceae) and Cardiopetalum calophyllum (Annonaceae). Braz J Biol 2020;80(2):290-294 View Article PubMed/NCBI
  23. Oliveira-Alves SC, Pereira RS, Pereira AB, Ferreira A, Mecha E, Silva AB, et al. Identification of functional compounds in baru (Dipteryx alata Vog.) nuts: Nutritional value, volatile and phenolic composition, antioxidant activity and antiproliferative effect. Food Res Int 2020;131:109026 View Article PubMed/NCBI
  24. Izumi C, Laure HJ, Barbosa NG, Thomé CH, Ferreira GA, Sousa JPB, et al. Sequesterpene Lactones Isolated from a Brazilian Cerrado Plant (Eremanthus spp.) as Anti-Proliferative Compounds, Characterized by Functional and Proteomic Analysis, are Candidates for New Therapeutics in Glioblastoma. Int J Mol Sci 2020;21(13):4713 View Article PubMed/NCBI
  25. Elias ST, Macedo CC, Simeoni LA, Silveira D, Magalhães PO, Lofrano-Porto A, et al. Cytotoxic effect of Erythroxylum daphnites extract is associated with G1 cell cycle arrest and apoptosis in oral squamous cell carcinoma. Cell Cycle 2016;15(7):948-956 View Article PubMed/NCBI
  26. Elias ST, Borges GA, Amorim DA, Rêgo DF, Simeoni LA, Silveira D, et al. Radiation induced a supra-additive cytotoxic effect in head and neck carcinoma cell lines when combined with plant extracts from Brazilian Cerrado biome. Clin Oral Investig 2015;19(3):637-646 View Article PubMed/NCBI
  27. Loverde-oliveira SM, Freitas MN, Araújo PKB, Costa IBC. Urban Cerrado fragment of the Federal University of Mato Grosso, Rondonópolis Campus, Mato Grosso. Revista Biodiversidade 2010;9(1):74
  28. Macedo TB, Elias ST, Torres HM, Yamamoto-Silva FP, Silveira D, Magalhães PO, et al. Cytotoxic Effect of Erythroxylum suberosum Combined with Radiotherapy in Head and Neck Cancer Cell Lines. Braz Dent J 2016;27(1):108-112 View Article PubMed/NCBI
  29. Medina RP, de Moura VM, da Silva CC, de Oliveira CMA, Kato L, Pomini AM, et al. Anti-inflammatory and antiproliferative activities of Ixora brevifolia Benth. (Rubiaceae). Nat Prod Res 2018;32(11):1357-1360 View Article PubMed/NCBI
  30. Lemes RS, Costa GCS, Silva DCS, Becceneri AB, Bicalho KU, Miranda MLD, et al. Essential oils of Kielmeyera coriacea fruits and leaves: antitumor activity and chemical study. Rev Virtual Quim 2017;9(3):1245-1257 View Article
  31. de Mesquita ML, Araújo RM, Bezerra DP, Filho RB, de Paula JE, Silveira ER, et al. Cytotoxicity of δ-tocotrienols from Kielmeyera coriacea against cancer cell lines. Bioorg Med Chem 2011;19(1):623-630 View Article PubMed/NCBI
  32. Figueiredo CR, Matsuo AL, Massaoka MH, Girola N, Azevedo RA, Rabaça AN, et al. Antitumor activity of kielmeyera coriacea leaf constituents in experimental melanoma, tested in vitro and in vivo in syngeneic mice. Adv Pharm Bull 2014;4(Suppl 1):429-436 View Article PubMed/NCBI
  33. Reichert CL, Silva DB, Carollo CA, Weffort-Santos AM, Santos CAM. Metabolic profiling and correlation analysis for the determination of killer compounds of proliferating and clonogenic HRT-18 colon cancer cells from Lafoensia pacari. J Ethnopharmacol 2018;224:541-552 View Article PubMed/NCBI
  34. Cordeiro YdeG, Rochetti AL, Souza VC, da Silva ER, Scatolini AM, Genovese MI, et al. Antineoplastic effect of procyanidin-rich extract of Lafoensia Pacari in lung carcinoma cells. Braz Arch Biol Technol 2019;62(7):e19160638 View Article
  35. da Silva Marcondes DB, Reichert CL, de Andrade LF, de Moraes Santos CA, Weffort-Santos AM. Cytotoxicity and apoptogenic effects of Lafoensia pacari. J Ethnopharmacol 2014;157:243-250 View Article PubMed/NCBI
  36. Funari CS, Passalacqua TG, Rinaldo D, Napolitano A, Festa M, Capasso A, et al. Interconverting flavanone glucosides and other phenolic compounds in Lippia salviaefolia Cham. ethanol extracts. Phytochemistry 2011;72(16):2052-2061 View Article PubMed/NCBI
  37. Saúde-Guimarães DA, Raslan DS, Oliveira AB. In Vitro antitumor activity of Sesquiterpene lactones from Lychnophora trichocarpha. Rev Bras Plantas Med 2014;16(2):275-282 View Article
  38. Costa PM, Ferreira PM, Bolzani Vda S, Furlan M, de Freitas Formenton Macedo Dos Santos VA, Corsino J, et al. Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells. Toxicol In Vitro 2008;22(4):854-863 View Article PubMed/NCBI
  39. Silva MJD, Carvalho AJS, Rocha CQ, Vilegas W, Silva MA, Gouvêa CMCP. Ethanolic extract of Mimosa caesalpiniifolia leaves: Chemical characterization and cytotoxic effect on human breast cancer MCF-7 cell line. S Afr J Bot 2014;93:64-69 View Article
  40. Serpeloni JM, Specian AF, Ribeiro DL, Tuttis K, Vilegas W, Martínez-López W, et al. Antimutagenicity and induction of antioxidant defense by flavonoid rich extract of Myrcia bella Cambess. in normal and tumor gastric cells. J Ethnopharmacol 2015;176:345-355 View Article PubMed/NCBI
  41. Dos Santos C, Galaverna RS, Angolini CFF, Nunes VVA, de Almeida LFR, Ruiz ALTG, et al. Antioxidative, Antiproliferative and Antimicrobial Activities of Phenolic Compounds from Three Myrcia Species. Molecules 2018;23(5):986 View Article PubMed/NCBI
  42. Soares PR, de Oliveira PL, de Oliveira CM, Kato L, Guillo LA. In vitro antiproliferative effects of the indole alkaloid vallesiachotamine on human melanoma cells. Arch Pharm Res 2012;35(3):565-571 View Article PubMed/NCBI
  43. Elias ST, Salles PM, de Paula JE, Simeoni LA, Silveira D, Guerra EN, et al. Cytotoxic effect of Pouteria torta leaf extracts on human oral and breast carcinomas cell lines. J Cancer Res Ther 2013;9(4):601-606 View Article PubMed/NCBI
  44. do Nascimento KF, Moreira FMF, Alencar Santos J, Kassuya CAL, Croda JHR, Cardoso CAL, et al. Antioxidant, anti-inflammatory, antiproliferative and antimycobacterial activities of the essential oil of Psidium guineense Sw. and spathulenol. J Ethnopharmacol 2018;210:351-358 View Article PubMed/NCBI
  45. Figueiredo CR, Matsuo AL, Pereira FV, Rabaça AN, Farias CF, Girola N, et al. Pyrostegia venusta heptane extract containing saturated aliphatic hydrocarbons induces apoptosis on B16F10-Nex2 melanoma cells and displays antitumor activity in vivo. Pharmacogn Mag 2014;10(Suppl 2):S363-S376 View Article PubMed/NCBI
  46. De Oliveira CR, Menezes ACS, de Moraes MO, Vieira LDM, Pereira AG, Lima RS, et al. Cytotoxic evaluation in three tumor cell lines of fractions obtained from the stem bark of Salacia crassifolia (MART. ex. Schult.) G. Dom. (Celastraceae). Rev Colomb Cienc Quím Farm 2012;41(2):133-142
  47. Espindola LS, Dusi RG, Demarque DP, Braz-Filho R, Yan P, Bokesch HR, et al. Cytotoxic Triterpenes from Salacia crassifolia and Metabolite Profiling of Celastraceae Species. Molecules 2018;23(6):1494 View Article PubMed/NCBI
  48. Campos JF, de Castro DT, Damião MJ, Vieira Torquato HF, Paredes-Gamero EJ, Carollo CA, et al. The Chemical Profile of Senna velutina Leaves and Their Antioxidant and Cytotoxic Effects. Oxid Med Cell Longev 2016;2016:8405957 View Article PubMed/NCBI
  49. Munari CC, de Oliveira PF, Campos JC, Martins Sde P, Da Costa JC, Bastos JK, et al. Antiproliferative activity of Solanum lycocarpum alkaloidic extract and their constituents, solamargine and solasonine, in tumor cell lines. J Nat Med 2014;68(1):236-241 View Article PubMed/NCBI
  50. Romero AL, Fontana A, da Silva CC, de Souza MC, de Carvalho JE, Faria EO, et al. Antiproliferative activity of Sloanea garckeana K. Schum. Quím Nova 2008;31(6):1359-1361 View Article
  51. Baldivia DDS, Leite DF, Castro DTH, Campos JF, Santos UPD, Paredes-Gamero EJ, et al. Evaluation of In Vitro Antioxidant and Anticancer Properties of the Aqueous Extract from the Stem Bark of Stryphnodendron adstringens. Int J Mol Sci 2018;19(8):2432 View Article PubMed/NCBI
  52. Rodrigues PSDM, Bertolin AO, Fucase TM, Galluzzi FM, Silva EC, Marumo Maria HB. Assessment of the cytotoxic activity of ethanol extracts from the bark and leaves of Terminalia fagifolia mart. on normal and tumor cells. J Health Biol Sci 2017;5(1):16-23 View Article
  53. Nascimento YM, Abreu LS, Lima RL, Silva ADS, Costa VCO, Melo JIM, et al. Zornioside, a dihydrochalcone C-glycoside, and other compounds from Zornia brasiliensis. Rev Bras Farmacogn 2018;28(2):3 View Article
  54. Seito LN, Ruiz AL, Vendramini-Costa D, Tinti SV, de Carvalho JE, Bastos JK, et al. Antiproliferative activity of three methoxylated flavonoids isolated from Zeyheria montana Mart. (Bignoniaceae) leaves. Phytother Res 2011;25(10):1447-1450 View Article PubMed/NCBI
  55. Karabegovic IT, Stojicevic SS, Velickovic DT, Todorovic ZB, Nikolic NC, Lazic ML. The effect of different extraction techniques on the composition and antioxidant activity of cherry laurel (Prunus laurocerasus) leaf and fruit extracts. Ind Crops Prod 2014;54:142-148 View Article
  56. Liu JM, Haroun-Bouhedja F, Boisson-Vidal C. Analysis of the in vitro inhibition of mammary adenocarcinoma cell adhesion by sulphated polysaccharides. Anticancer Res 2000;20(5A):3265-3271 PubMed/NCBI
  57. Toropainen E, Ranta VP, Talvitie A, Suhonen P, Urtti A. Culture model of human corneal epithelium for prediction of ocular drug absorption. Invest Ophthalmol Vis Sci 2001;42(12):2942-2948 PubMed/NCBI
  58. Hubrecht RC, Carter E. The 3Rs and Humane Experimental Technique: Implementing Change. Animals (Basel) 2019;9(10):754 View Article PubMed/NCBI
  59. Daniyan MO, Omisore NO, Adeyemi OI, Olusa AS, Olaniran SF, Oyemitan IA, et al. An Improved Method for Toxicological Profiling of Chemical Substances. Toxicol Mech Methods 2024;12:1-50 View Article PubMed/NCBI
Copyright © 2024 Authors. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 License (CC BY-NC 4.0), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • Future Integrative Medicine
  • pISSN 2993-5253
  • eISSN 2835-6357

Article Options

Metrics

Cite this Article

  • © 2024 Xia & He Publishing Inc.
  • Total visits : 2585784
  • Visits today : 3779
Back to Top

Activity of Brazilian Cerrado Plants in Tumor Cell Lines: A Systematic Review

Gabriela Silva Neubern de Oliveira, Cassia Senger, Rodrigo Cardoso de Oliveira
  • Reset Zoom
  • Download TIFF